New Lung Cancer Treatment Approved: Ibtrozi Targets ROS1-Positive NSCLC
The U.S. Food and Drug Administration (FDA) has approved a new pill called Ibtrozi (taletrectinib) for treating a rare type of lung cancer known as ROS1-positive non-small cell lung cancer…